New brain biomarker identifies pain sensitivity and may predict chronic pain risk

Post author:admin
Post published:January 28, 2025
Post category:uncategorized

A novel biomarker signature combining PAF and CME predicts chronic pain risk, linking brain activity to individual pain sensitivity and treatment strategies.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

New drug approach shows promise in treating metabolic liver diseases

New intramuscular mRNA vaccine offers easier alternative to treat neovascular eye diseases

Weill Cornell scientists discover early step in fat cell inflammation leading to diabetes

Helpful Links

Subscribe To Us